Katie Wood

Pertuzumab and Erlotinib in Patients With Relapsed Non-Small Cell Lung Cancer: A Phase II Study Using 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Imaging

Brett Hughes, Linda Mileshkin, P. Townley et al. · The Oncologist · 2014 · 23 citations · Full text

Randomized Phase 3 Trial of the Hypoxia Modifier Nimorazole Added to Radiation Therapy With Benefit Assessed in Hypoxic Head and Neck Cancers Determined Using a Gene Signature (NIMRAD)

David Thomson, N.J. Slevin, Helen Baines et al. · International Journal of Radiation Oncology*Biology*Physics · 2023 · 19 citations · Full text

Volumetric-modulated arc therapy (RapidArc) vs. conventional fixed-field intensity-modulated radiotherapy for 18F-FDG-PET-guided dose escalation in oropharyngeal cancer: A planning study

May Teoh, Sabeena Beveridge, Katie Wood et al. · Medical dosimetry · 2012 · 10 citations